Monsanto Co. is still relatively fresh off a losing effort to acquire the Swiss firm Syngenta AG, but analysts say the Creve Coeur-based company still has options for acquisition.
In October, Dow Chemical Co. said it is considering selling off its agroscience unit. DuPont’s interim CEO also said late last month that the company is considering the sale of its agricultural unit. Not so long ago Bayer’s CropScience unit was talked of as a possible acquisition target, though that company’s chief executive told the Financial Times recently that the company wanted to be a buyer, not seller.
Dow is far smaller than Syngenta, with about $7.3 billion in sales in 2014 as compared with $15.1 billion for Syngenta. But it, like Syngenta, offers Monsanto the possibility of developing seeds alongside chemicals within the same research pipeline and being able to sell a wider range of products to farmers.